Knockdown of lncRNA NUTM2A‑AS1 inhibits lung adenocarcinoma cell viability by regulating the miR‑590‑5p/METTL3 axis
2021 · Oncology Letters · 29 citations
https://doi.org/10.3892/ol.2021.13059
X
Xiaolin Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
678
Citations
15
h-index
18
i10-index
Xiaolin Wang is an academic researcher from Shanxi Medical University. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Cancer-related molecular mechanisms research & Cancer, Hypoxia, and Metabolism. The author has an h-index of 15, co-authored 36 publications.
ORCID: 0000-0002-7851-2650Papers by this author
worksMultidimensional pan-cancer analysis of HSPA5 and its validation in the prognostic value of bladder cancer
2024 · Heliyon · 23 citations
https://doi.org/10.1016/j.heliyon.2024.e27184
Increased miR-141 expression is associated with diagnosis and favorable prognosis of patients with bladder cancer
2014 · Tumor Biology · 16 citations
https://doi.org/10.1007/s13277-014-2656-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat